HC Wainwright Analysts Give Summit Therapeutics (SMMT) a $20.00 Price Target

Retrieved on: 2018-05-14 06:41:15

Tags for this article:

Money

Finance

Click the tags to see associated articles and topics

HC Wainwright Analysts Give Summit Therapeutics (SMMT) a $20.00 Price Target. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> LLC lifted its stake in Summit Therapeutics by 192.8% during the 4th quarter. <b>Acadian Asset Management</b> LLC now owns ...</div>

Article found on:

View Original Article